Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19129346 | 0.89 | TAAR1 (0.48) | TAAR1ADRA1DADRA2AADRA2BADRA2C | |
| SCHEMBL30505689 | 0.84 | CYP2C9 (0.50) | TAAR1ADRA1DADRA2AADRA2BADRA2C | |
| Acetic Acid SCHEMBL11332370 | 0.83 | CYP2C19 (0.57) | CYP2C19LMNACYP2C9POLBTDP1 | |
| SCHEMBL3159038 | 0.82 | ADRA2A (0.61) | TAAR1ADRA2AADRA2BADRA2CCYP2C19 | |
| SCHEMBL45228 | 0.82 | LMNA (0.50) | TAAR1ADRA1DCYP2C19LMNATSHR | |
| Glycolic Acid SCHEMBL9067480 | 0.82 | CYP2C19 (0.55) | CYP2C19LMNACYP2C9HTTPOLB | |
| SCHEMBL2030841 | 0.81 | TAAR1 (0.71) | TAAR1ADRA2AADRA2BADRA2CCYP2C19 | |
| SCHEMBL21386931 | 0.80 | PRMT6 (0.48) | TAAR1ADRA1DLMNATSHRCYP2C9 | |
| SCHEMBL920428 | 0.80 | ADRA1D (0.43) | TAAR1ADRA1DADRA2AADRA2BADRA2C | |
| SCHEMBL8879459 | 0.80 | TAAR1 (0.41) | TAAR1ADRA1DADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117835718-A | White light organic electroluminescent composition and application thereof | 深圳大学 | 2024-04-05 | — | — | CN | claimed |
| US-10903109-B2 | Methods of forming high aspect ratio openings and methods of forming high aspect ratio features | MICRON TECHNOLOGY, INC. (US) | 2021-01-26 | — | — | US | claimed |
| JP-4838934-B2 | — | — | 2011-12-14 | — | — | JP | claimed |
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | ENCYSIVE PHARMACEUTICALS, INC. | 2008-08-07 | — | — | US | claimed |
| EP-1042291-B1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE CO CHEM PHARM FAB (DE) | 2005-07-13 | — | — | EP | claimed |
| EP-1042291-A1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | claimed |
| WO-1999031064-A1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | claimed |
| EP-0352612-B1 | PROCESS FOR THE PRODUCTION OF A PRINTING PLATE | M.A.N.-ROLAND Druckmaschinen Aktiengesellschaft (DE) | 1993-03-10 | — | — | EP | claimed |
| US-4092306-A | Oxidation of hydrazones to the corresponding diazo compounds in the presence of a phase transfer and an oxidation catalyst which is iodine, an iodide or an iodonium salt | GLAXO LABORATORIES LIMITED (EN) | 1978-05-30 | — | — | US | claimed |
| CN-117835718-A | White light organic electroluminescent composition and application thereof | 深圳大学 | 2024-04-05 | — | — | CN | disclosed |
| US-20230346766-A1 | TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION | WHITEHAWK CAPITAL PARTNERS, LP | 2023-11-02 | — | — | US | disclosed |
| WO-2023285760-A1 | COMPOSITION BASED ON (METH)ACRYLATE MONOMERS | BOSTIK SA (FR) | 2023-01-19 | — | — | WO | disclosed |
| US-20220363538-A1 | HYDROGEN PEROXIDE PRODUCTION METHOD | INTERNATIONAL FRONTIER TECHNOLOGY LABORATORY, INC. (JP) | 2022-11-17 | — | — | US | disclosed |
| CN-113493393-A | Method for olefin chemoselective monofunctional reaction under base catalysis | 南京工业大学 | 2021-10-12 | — | — | CN | disclosed |
| WO-1987000678-A1 | ELECTRICALLY CONDUCTING POLYMERS | SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MA (GB) | 1987-01-29 | — | — | WO | disclosed |
| US-4611032-A | DOPED HETEROAROMATIC 5-MEMBER RING POLYMERS | Chatzitheodorou, Georg (DE) | 1986-09-09 | — | — | US | disclosed |
| US-4501903-A | PASSING RAPID STREAM OF GASEOUS HYDROGEN CHLORIDE IN REACTION MIXTURE OF FORMALDEHYDE THIOPHENE AND AQUEOUS HYDROGENCHLORIDE | STAUFFER CHEMICAL COMPANY (US) | 1985-02-26 | — | — | US | disclosed |
| EP-0097893-A2 | Oxidizing polymerisation with NO+ or NO2+ | BAYER AG (DE) | 1984-01-11 | — | — | EP | disclosed |
| US-4415566-A | ANTIBIOTICS; BACTERIOSTATS; BACTERICIDES | BOEHRINGER INGELHEIM GMBH (DE) | 1983-11-15 | — | — | US | disclosed |
| US-4085109-A | Pyridine sulfur flavoring agents | FIRMENICH & CIE (CH) | 1978-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188528-A1 | Modulators of C3a receptor and methods of use thereof | C3AR1, C5, C5AR1 | TAAR1 718/4885ADRA1D 511/4885ADRA2A 199/4885 |
| US-20230346766-A1 | TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION | IL5, CFTR, THOP1 | TAAR1 1444/4885ADRA1D 153/4885ADRA2A 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.